Bile acids influence hepatic chemiluminescence in normal and oxidative-stressed rats

J Gastroenterol Hepatol. 1998 Jan;13(1):81-7. doi: 10.1111/j.1440-1746.1998.tb00550.x.

Abstract

The aim of the present study was to clarify whether bile acids influence chemiluminescence (CL) in the liver in vivo. Hepatic CL was determined on the surface of the liver of anaesthetized rats by using a photon counter. In normal rats, hepatic CL was significantly decreased 30 min after enteral administration of chenodeoxycholic acid (CDCA) or deoxycholic acid (DCA), but returned to its initial level 3 h later, after part of the CDCA administered was metabolized. Ursodeoxycholic acid (UDCA) and cholic acid had no effect on CL. In contrast, hepatic CL was markedly increased 30 min after CDCA or DCA administration in rats given either buthionine sulphoximine (BSO), an inhibitor of gamma-glutamylcysteine synthetase, or diethyldithiocarbamate (DDC), an inhibitor of both superoxide dismutase and glutathione peroxidase. Chenodeoxycholic acid further increased the CL of BSO- or DDC-treated rats during inhalation of oxygen via a tracheal cannula. Coadministration of UDCA eliminated the effects of CDCA on the hepatic CL of normal and BSO- or DDC-treated rats with or without oxygen inhalation. We conclude that cytotoxic bile acids, such as CDCA, increase CL in the antioxidants-depleted or oxidative-stressed liver in vivo, but that UDCA prevents CDCA from developing CL.

MeSH terms

  • Animals
  • Bile Acids and Salts / metabolism*
  • Bile Acids and Salts / pharmacology
  • Glutathione / metabolism
  • Lipid Peroxidation
  • Liver / metabolism*
  • Liver / pathology
  • Luminescent Measurements*
  • Male
  • Oxidative Stress*
  • Rats
  • Rats, Wistar

Substances

  • Bile Acids and Salts
  • Glutathione